Home › Funds › Bridgewater Associates › TXG
Bridgewater Associates position in TXG
10X GENOMICS INC · Industrials
Latest position (Q2 2026)13.38K sh
Reported value held$512.80K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.99K | $289.00K | New |
| Q1 2022 | 6.18K | $470.00K | New |
| Q2 2022 | 8.68K | $393.00K | Add |
| Q4 2022 | 13.04K | $475.32K | New |
| Q4 2025 | 177.73K | $2.90M | New |
| Q1 2026 | 35.10K | $745.19K | Reduce |
| Q2 2026 | 13.38K | $512.80K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TXG
- Fidelity Management & Research (FMR) 17.63M sh · $675.91M · Q2 2026
- BlackRock Inc 10.80M sh · $414.23M · Q2 2026
- ARK Invest 10.00M sh · $383.52M · Q2 2026
- Vanguard Group 13.02M sh · $212.32M · Q4 2025
- Morgan Stanley 3.35M sh · $128.51M · Q2 2026
- Goldman Sachs Group 3.15M sh · $120.73M · Q2 2026
- Geode Capital Management 3.08M sh · $118.22M · Q2 2026
- AQR Capital Management 2.03M sh · $74.70M · Q2 2026
- Point72 Asset Management 1.85M sh · $71.04M · Q2 2026
- Capital World Investors 1.49M sh · $57.24M · Q2 2026
- Northern Trust Corp 1.14M sh · $43.86M · Q2 2026
- Charles Schwab Investment Management 1.09M sh · $41.68M · Q2 2026